In a May 27 request for dismissal in a class action lawsuit brought against the company, dietary supplement firm GOLO L.L.C. stated that the issue of whether its product in question “should be regulated as a drug and thus be subjected to restrictive premarket approval processes because of those claims is a legal position that the FDA has the sole discretion to advocate.” GOLO ... Read More